FDA Approves Immunotherapy for MSI-High or MMR-Deficient Tumors

FDA Approves Immunotherapy for MSI-High or MMR-Deficient Tumors

It is indicated for the treatment of adults and pediatric patients with unresectable or metastatic solid tumors that have been identified as having the biomarker microsatellite instability-high (MSI-H) or mismatch fix deficient (dMMR), according to a press release.

It's also great news for the drug maker Merck, and it came at the ideal time; earlier the same day, the UK's Competition and Markets Authority accused the US-based pharma company of "offering unfair discounts" on infliximab, its blockbuster rheumatoid arthritis and Crohn's disease drug, to "discourage new competitors", according to the Financial Times. This time, Keytruda won a go-ahead to treat any solid tumor in any part of the body, as long as it bears specific genetic features.

Keytruda belongs to a new class of drugs called PD-1 or PD-L1 inhibitors that help the immune system fight cancer by blocking a mechanism tumors use to evade detection.

The drug is now indicated for adult and pediatric patients with unresectable or metastatic microsatellite instability-high or mismatch fix deficient solid tumors that lack suitable alternative treatments or that have progressed on treatment. MSI-H and dMMR occur most often in colorectal, endometrial, and gastrointestinal cancers (including about 5% of patients with metastatic colorectal cancer).

Researchers found the drug's safety and efficacy in five uncontrolled, single-arm clinical trials with patients who have MSI-H or dMMR solid tumors. The ORR was 36 percent in patients with CRC and 46 percent in patients with other tumor types. For 78 percent of those patients, the response lasted for six months or more.

Merck's cancer drug also has become the first to receive an approval of this kind, seeing a 1 percent increase in its shares following the announcement.

"This is an important first for the cancer community", said Dr. Richard Pazdur, director of oncology products at the FDA's Center for Drug Evaluation and Research, in a statement.

In the initial studies nearly 40% of patients saw a partial or complete response with Keytruda at a fixed dose of 200mg every three weeks, and in 78% of them the effect lasted for at least six months.

Common adverse events due to pembrolizumab included constipation, cough, decreased appetite, diarrhea, dyspnea, fatigue, musculoskeletal pain, nausea, pruritus, pyrexia, and rash. The FDA previously approved Keytruda for the treatment of certain patients with metastatic melanoma, metastatic non-small cell lung cancer, recurrent or metastatic head and neck cancer, refractory classical Hodgkin lymphoma, and urothelial carcinoma. Immune-mediated side effects are also associated with pembrolizumab; these include colitis, endocrinopathies, hepatitis, nephritis, and pneumonitis. The approval was preceded by a breakthrough therapy designation the FDA granted to pembrolizumab in November 2015 as a treatment for patients with MSI-H metastatic CRC.

The accelerated approval for Keytruda in this setting is contingent on the results of a confirmatory trial. MSI-H is already an established biomarker in certain types of cancer.

Related Articles

  • Trump due on Egypt visit to mend soured ties under Obama

    Trump due on Egypt visit to mend soured ties under Obama

    Egypt is also keen to have Western companies invest in the country, to prop up it dire economy. President Donald Trump is making plans for another foreign trip as he eases into his first.

    Netanyahu orders Cabinet to attend Trump arrival ceremony

    Trump's remark during that news conference is the clearest statement of policy on the issue from the administration to date. Trump's fierce pro-Israel stance has limits, and just like past USA presidents, Trump has his own agenda, Herzog suggested.

    Hugo Lloris 'gutted' at Tottenham's failure against West Ham United

    West Ham kept Tottenham at arm's length once it went ahead and the final whistle sparked scenes of jubilation around the ground. It's not about playing well or running around more or less, it's about when you must win, you win.
  • Ex-CIA Chief Says He Warned Russians About Election Meddling

    He said there appear to be "very, very damaging leaks, and I find them appalling and they need to be tracked down". He told committee members there had not been a good relationship between Putin and the Clintons over the years.

    Report Claims Trump Told Russians 'Nut Job' Comey's Dismissal Eased Pressure

    Comey will testify publicly before the Senate intelligence committee after Memorial Day, the panel's leaders announced Friday. President Trump has been narrowing a short list and interviewing candidates to replace Comey, whom Trump fired on May 9.
    Iowa Governor Branstad confirmed as US Ambassador to China

    Iowa Governor Branstad confirmed as US Ambassador to China

    I'm honored to have the opportunity today to speak to my colleagues about my good friend, Governor Terry Branstad . With more than 22 years at the helm of state government, he is the country's longest serving governor.
  • 'Dancing With The Stars' Finale Recap: A Night Full Of Perfect Scores

    Yowza! Normani is still my favorite to win - she's been the most consistent and has shown steady improvement over the season. The likable football player improves every single week and on night one of the finale on May 22, he got TWO PERFECT SCORES .
    Soundgarden frontman Cornell's funeral will be Friday in LA

    Soundgarden frontman Cornell's funeral will be Friday in LA

    The funeral is slated to take place in Los Angeles, and Chris Cornell will be interred at the Hollywood Forever Cemetery. Vicky told Kirsten that Cornell repeated, 'I am just exhausted , ' before hanging up the phone, the report says.
    After Yates, more questions for the Trump White House

    After Yates, more questions for the Trump White House

    He said then she informed the White House counsel's office that there were materials relevant to the situation involving Flynn. Trump turned to Twitter to talk back after Yates' testimony Monday.
  • Germany, France pledge new effort to strengthen eurozone

    Germany, France pledge new effort to strengthen eurozone

    This was the first meeting between the representatives of the two largest economies in Europe, after Emmanuel Macron's election as the French President.

    Saudi says extending oil cuts, adding small producers enough to drain stocks

    So maintaining the current discipline of production cuts is key and we expect the current quotas to hold for the most part. Iran was also allowed to raise output because sanctions had crippled its supply.
    Westpac says bank levy will cost it $260ma year

    Westpac says bank levy will cost it $260ma year

    With the legislation yet to pass the parliament, Mr Maxsted said the bank would be pushing for foreign banks to also be included. Worldwide rivals would not be subject to the levy, although HSBC is subject to the equivalent United Kingdom scheme.